Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-049118

Director sold 15,593 shares at an average $45.01 ($701,774)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Prokupets Elena Director 2021-07-29 Sale −11,336 $45.00 $510,168 107,238 I: show line 1 in the form
Prokupets Elena Director 2021-08-02 Sale −4,257 $45.01 $191,606 102,981 I: show line 2 in the form
Open-market sales · 15,593 sh · avg $45.01 · $701,774
Loading xslF345X03/doc4.xml…